WST

NYSE

WEST PHARMACEUTICAL SERVICES INC

Health Care, Health Care Supplies

$354.07

close 7 Aug 2026

+47.33%

52-week change

$24.93B

market cap

$223.83

$386.00

52-week range

Expected price

$306.13 – $374.15

Current price

$354.07

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)45.34x

P/S (TTM)7.49x

P/B8.34x

EV/EBITDA (TTM)28.65x

FCF yield (TTM)1.75%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average42.74x

P/E, sector median29.65x*

Price at 5-year median P/E$335.48*

Indicated dividend yield0.25%

Forward — analyst consensus

Forward P/E (FY2026)39.52x*

Forward P/E (FY2027)35.53x

Forward PEG3.52*

Consensus EPS FY2026 (16 analysts)$8.96

EPS growth (FY2026→FY2027)11.23%

Revenue growth (FY2026)9.77%

Street view

Price target (mean)$404.73*

Target upside14.31%

Ratings (buy / hold / sell)14 / 2 / 0

FY2026 EPS revisions, 30d (up / down)13 / 1

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 23 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +9.48%10Y CAGR +19.22%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$354.07

Cash & equivalents$435.80M

Total debt$202.90M

Shares outstanding70.40M

Result

DCF price per share$202.76

Current price$354.07

Margin of safety-42.73%

PV of years 1–10$4.71B

PV of terminal value$9.33B

Equity value$14.27B

Market-implied growth+16.79%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$478.32M	$523.66M	$573.31M	$627.66M	$687.16M	$752.30M	$823.62M	$901.70M	$987.18M	$1.08B	$20.14B
PV	$442.89M	$448.96M	$455.11M	$461.35M	$467.67M	$474.08M	$480.57M	$487.16M	$493.83M	$500.60M	$9.33B

period to 30 Jun 2026, filed 23 Jul 2026, close 7 Aug 2026